NEW: Redenlab sign agreement with Monash Institute of Cognitive and Clinical Neurosciences

  • Posted on March 5, 2018
  • by Redenlab
  • Blog

Redenlab are working with the Monash University Sleep group

Tags: , ,

Related Post

The L16HTHOUSE Study

  • Posted on 30 March, 2023
    L16HTHOUSE is a research trial testing an experimental medication for treating speech, motor, learning, and other developmental delays in children...
    Read more

    Dietary fat supplement trial for A-T

    • Posted on 30 March, 2023
      Ataxia telangiectasia (A-T) is a rare inherited condition that affects the nervous and immune systems. A-T typically impacts movement, vision...
      Read more

      Temporary Assessment of Language in Kabuki Syndrome (TALK) Study

      • Posted on 30 March, 2023
        Speech and language development is a complex, multifactorial process driven by the individual’s ability to process and formulate communication. These...
        Read more